Ellevest Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $666K | Buy |
2,716
+237
| +10% | +$51K | 0.08% | 188 |
|
|
2026
Q1 | $539K | Buy |
2,479
+38
| +2% | +$8.43K | 0.08% | 205 |
|
|
2025
Q4 | $558K | Sell |
2,441
-8
| -0.3% | -$1.82K | 0.08% | 195 |
|
|
2025
Q3 | $567K | Sell |
2,449
-31
| -1% | -$6.31K | 0.08% | 198 |
|
|
2025
Q2 | $460K | Buy |
2,480
+26
| +1% | +$4.83K | 0.07% | 208 |
|
|
2025
Q1 | $514K | Sell |
2,454
-33
| -1% | -$6.42K | 0.03% | 185 |
|
|
2024
Q4 | $442K | Sell |
2,487
-207
| -8% | -$38.1K | 0.03% | 226 |
|
|
2024
Q3 | $532K | Buy |
2,694
+24
| +0.9% | +$4.48K | 0.03% | 200 |
|
|
2024
Q2 | $458K | Buy |
2,670
+417
| +19% | +$69.1K | 0.03% | 223 |
|
|
2024
Q1 | $410K | Buy |
2,253
+272
| +14% | +$46.9K | 0.03% | 247 |
|
|
2023
Q4 | $307K | Buy |
1,981
+112
| +6% | +$16.3K | 0.02% | 289 |
|
|
2023
Q3 | $279K | Sell |
1,869
-61
| -3% | -$8.96K | 0.02% | 276 |
|
|
2023
Q2 | $260K | Buy |
1,930
+75
| +4% | +$11K | 0.02% | 293 |
|
|
2023
Q1 | $296K | Buy |
1,855
+20
| +1% | +$3.06K | 0.02% | 239 |
|
|
2022
Q4 | $297K | Sell |
1,835
-561
| -23% | -$86K | 0.03% | 233 |
|
|
2022
Q3 | $322K | Sell |
2,396
-456
| -16% | -$65.4K | 0.03% | 171 |
|
|
2022
Q2 | $437K | Sell |
2,852
-214
| -7% | -$32.7K | 0.04% | 121 |
|
|
2022
Q1 | $497K | Buy |
3,066
+249
| +9% | +$36.2K | 0.04% | 121 |
|
|
2021
Q4 | $381K | Sell |
2,817
-396
| -12% | -$46.8K | 0.03% | 160 |
|
|
2021
Q3 | $347K | Buy |
3,213
+612
| +24% | +$69.9K | 0.03% | 159 |
|
|
2021
Q2 | $293K | Sell |
2,601
-537
| -17% | -$60.5K | 0.03% | 178 |
|
|
2021
Q1 | $340K | Buy |
3,138
+30
| +1% | +$3.21K | 0.04% | 110 |
|
|
2020
Q4 | $333K | Sell |
3,108
-1,379
| -31% | -$133K | 0.05% | 88 |
|
|
2020
Q3 | $393K | Sell |
4,487
-469
| -9% | -$44.2K | 0.07% | 78 |
|
|
2020
Q2 | $487K | Buy |
4,956
+3,631
| +274% | +$320K | 0.1% | 49 |
|
|
2020
Q1 | $101K | Buy |
1,325
+130
| +11% | +$11.1K | 0.03% | 138 |
|
|
2019
Q4 | $106K | Buy |
1,195
+738
| +161% | +$61.3K | 0.03% | 102 |
|
|
2019
Q3 | $35K | Buy |
457
+25
| +6% | +$1.71K | 0.01% | 140 |
|
|
2019
Q2 | $31K | Sell |
432
-53
| -11% | -$4.17K | 0.01% | 168 |
|
|
2019
Q1 | $39K | Buy |
485
+229
| +89% | +$18.7K | 0.02% | 101 |
|
|
2018
Q4 | $24K | Buy |
+256
| New | +$22.5K | 0.01% | 299 |
|
Other funds holding ABBV
Ellevest Inc's ABBV Position: Q2 2026 in Review
Ellevest Inc increased its AbbVie (ABBV) stake by 9.6% in Q2 2026, buying an estimated $51K and bringing the position to 2,716 shares worth $666K. The position accounts for 0.08% of the portfolio, ranked #188.
Ellevest Inc first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Ellevest Inc held 2,716 shares of AbbVie worth $666K as of Q2 2026.
- Ellevest Inc bought 237 AbbVie shares in Q2 2026, an estimated $51K.
- AbbVie made up 0.08% of Ellevest Inc's portfolio in Q2 2026, its #188 holding.
- Ellevest Inc first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.